Dr. Michael W. Mcdermott, M.D.
Neurosurgery (Neurological Surgery Physician)
- Medicare participating
At a glance
- Years since graduation
- 44
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 67
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Neurological Surgery Physician primary
FL license ME143472 -
Specialist
CA license A44736
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Baptist Hospital of Miami Miami, FL
Medical groups
- Baptist Health Medical Group Physicians LLC (670 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 67
- Services billed
- 134
- Patients’ average age
- 72
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 20-29 minutes | 18 | 15 |
| New patient office or other outpatient visit, 30-44 minutes | 17 | 17 |
| Computer-assisted radiosurgery application of headframe | 16 | 14 |
| Established patient office or other outpatient visit, 10-19 minutes | 15 | 13 |
| Computer-assisted radiosurgery of simple growth of brain, first growth | 15 | 13 |
| Computer-assisted radiosurgery of simple growth of brain, each additional growth | 13 | 11 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 12 | 11 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Payments from drug and device companies
In 2025, 6 companies reported 15 payments worth $1,468 in total to this clinician.
| Clearpoint Neuro, Inc. | $1,126 |
|---|---|
| Medtronic, Inc. | $153 |
| Elekta, Inc. | $125 |
| AstraZeneca Pharmaceuticals LP | $25.00 |
| Acumed LLC | $22.23 |
| Acadia Pharmaceuticals Inc | $16.84 |
| Travel and Lodging | $982 |
|---|---|
| Food and Beverage | $485 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Clearpoint Neuro, Inc. Mar 5, 2025 | Travel and Lodging CLEARPOINT · Neurology · travel to San Diego, CA · in-kind | $524 |
| Clearpoint Neuro, Inc. Feb 5, 2025 | Travel and Lodging CLEARPOINT · Neurology · travel to San Diego, CA · in-kind | $407 |
| Clearpoint Neuro, Inc. Feb 26, 2025 | Travel and Lodging CLEARPOINT · Neurology · travel to San Diego, CA · in-kind | $33.22 |
| Clearpoint Neuro, Inc. Feb 25, 2025 | Travel and Lodging CLEARPOINT · Neurology · travel to San Diego, CA · in-kind | $18.03 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $2,882 in research payments for these studies, mostly to the institutions running them.
- Assessment of Safety and Efficacy of Exablate Blood Brain Barrier Disruption for the Treatment of Patients with Probable Alzheimers Disease – AL002
Insightec,ltd
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.